Applied Therapeutics Shares Surge as Legal Settlement Fuels Investor Confidence

Technical Momentum Builds

Shares of Applied Therapeutics experienced a dramatic upswing on Tuesday, posting an impressive gain of over 11%. The stock reached $1.13, continuing a substantial rally that has been building momentum over recent weeks.

From a technical perspective, the current price movement is remarkable. The equity has surged nearly 90% within a single week and has advanced more than 150% over the past month. Trading well above its 50-day moving average, the stock demonstrates clear bullish sentiment in the short term. However, questions remain about whether this momentum-driven enthusiasm can be sustained, particularly given the biotechnology sector’s notorious volatility.

Resolving Legal Challenges